Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: An observational study

Obesity Research and Clinical Practice

Volumn 8, Issue 4, 2014, Pages

  Haider, Ahmad ^a   Saad, Farid ^b,c   Doros, Gheorghe ^d   Gooren, Louis ^e,f  

^a Private Urology Practice   (Germany)

^b BAYER PHARMA AG   (Germany)

^c GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Androconsult   (Thailand)

Author keywords

Diabetes mellitus type 2; Obesity; Testosterone; Waist circumference; Weight loss

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A1C; LIPID; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HYPOGONADISM; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PARENTERAL NUTRITION; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HEMATOCRIT; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HUMANS; HYPOGONADISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TESTOSTERONE; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84905594213     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2013.10.005     Document Type: Article

References (51)

1. E.M. Mathus-Vliegen Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline Obes Facts 5 3 2012 460 483
2. A. Astrup, S. Rossner, N. Finer, and L. Van Gaal Obesity in Europe - does anybody care? Expert Opin Pharmacother 14 8 2013 971 973
3. K.M. Flegal, B.K. Kit, H. Orpana, and B.I. Graubard Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis JAMA 309 1 2013 71 82
4. T. von Lengerke, and C. Krauth Economic costs of adult obesity: a review of recent European studies with a focus on subgroup-specific costs Maturitas 69 3 2011 220 229
5. T.A. Wadden, S. Volger, D.B. Sarwer, M.L. Vetter, A.G. Tsai, and R.I. Berkowitz et al. A two-year randomized trial of obesity treatment in primary care practice N Engl J Med 365 21 2011 1969 1979
6. J.R. Taylor, E. Dietrich, and J.G. Powell New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity Clin Ther 35 1 2013 A3 A17
7. M. Schmidt, S.A. Johannesdottir, S. Lemeshow, T.L. Lash, S.P. Ulrichsen, and H.E. Botker et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study BMJ Open 3 4 2013
8. F.C. Wu, A. Tajar, S.R. Pye, A.J. Silman, J.D. Finn, and T.W. O'Neill et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study J Clin Endocrinol Metab 93 7 2008 2737 2745
9. R. Haring, H. Volzke, S.B. Felix, S. Schipf, M. Dorr, and D. Rosskopf et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania Diabetes 58 9 2009 2027 2031
10. G. Corona, G. Rastrelli, M. Monami, F. Saad, M. Luconi, and M. Lucchese et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis Eur J Epidemiol 168 2013 829 843
11. G. Corona, E. Mannucci, V. Ricca, F. Lotti, V. Boddi, and E. Bandini et al. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction Int J Androl 32 6 2009 720 728
12. C. Li, E.S. Ford, B. Li, W.H. Giles, and S. Liu Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men Diab Care 33 7 2010 1618 1624
13. F. Saad, A. Aversa, A.M. Isidori, and L.J. Gooren Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review Curr Diab Rev 8 2012 131 143
14. F. Saad, and L.J. Gooren The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2 J Obes 2011 Article ID 471584
15. A.M. Traish, R.J. Feeley, and A. Guay Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction FEBS 276 20 2009 5755 5767
16. M. Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome Nat Rev Endocrinol 5 12 2009 673 681
17. M.A. Gates, R.A. Mekary, G.R. Chiu, E.L. Ding, G.A. Wittert, and A.B. Araujo Sex steroid hormone levels and body composition in men J Clin Endocrinol Metab 98 6 2013 2442 2450
18. E.M. Camacho, I.T. Huhtaniemi, T.W. O'Neill, J.D. Finn, S.R. Pye, and D.M. Lee et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study Eur J Epidemiol 168 3 2013 445 455
19. S.A. Saboor Aftab, S. Kumar, and T.M. Barber The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism Clin Endocrinol 78 3 2013 330 337
20. D.M. Kelly, and T.H. Jones Testosterone: a metabolic hormone in health and disease J Endocrinol 217 2013 R25 R45
21. A.M. Traish, and K.E. Kypreos Testosterone and cardiovascular disease: an old idea with modern clinical implications Atherosclerosis 214 2 2011 244 248
22. P.J. Saylor, and M.R. Smith Metabolic complications of androgen deprivation therapy for prostate cancer J Urol 189 Suppl. 1 2013 S34 S42 discussion S3-4
23. E.J. Hamilton, E. Gianatti, B.J. Strauss, J. Wentworth, D. Lim-Joon, and D. Bolton et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy Clin Endocrinol 74 3 2011 377 383
24. F. Saad Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? Diabetes Metab Res Rev 28 Suppl. 2 2012 52 59
25. A. Morgentaler Testosterone and prostate cancer: what are the risks for middle-aged men? Urol Clin North Am 38 2 2011 119 124
26. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 16 2005 1685 1695
27. S. Klein, D.B. Allison, S.B. Heymsfield, D.E. Kelley, R.L. Leibel, and C. Nonas et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASOM, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association Am J Clin Nutr 85 5 2007 1197 1202
28. J.P. Dépres, I. Lemieux, and D. Prud'homme Treatment of obesity: need to focus on high risk abdominally obese patients BMJ 322 7288 2001 716 720
29. J. Svartberg, D. von Muhlen, J. Sundsfjord, and R. Jorde Waist circumference and testosterone levels in community dwelling men. The Tromso study Eur J Epidemiol 19 7 2004 657 663
30. B. Balkau, J.E. Deanfield, J.P. Dépres, J.P. Bassand, K.A. Fox, and S.C. Smith Jr. et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries Circulation 116 17 2007 1942 1951
31. T. Pischon, H. Boeing, K. Hoffmann, M. Bergmann, M.B. Schulze, and K. Overvad et al. General and abdominal adiposity and risk of death in Europe N Engl J Med 359 20 2008 2105 2120
32. S. Bose, P. Krishnamoorthy, A. Varanasi, J. Nair, M. Schutta, and S. Braunstein et al. Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokines Obesity 21 1 2013 E118 E123
33. E.J. Jacobs, C.C. Newton, Y. Wang, A.V. Patel, M.L. McCullough, and P.T. Campbell et al. Waist circumference and all-cause mortality in a large US cohort Arch Int Med 170 15 2010 1293 1301
34. I. Lemieux, A. Pascot, C. Couillard, B. Lamarche, A. Tchernof, and N. Almeras et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 2 2000 179 184
35. S. Sam, S. Haffner, M.H. Davidson, R.B. D'Agostino Sr., S. Feinstein, and G. Kondos et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes Diab Care 32 10 2009 1916 1920
36. F. Saad, A. Haider, G. Doros, and A. Traish Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss Obesity 21 10 2013 1975 1981
37. L.A. Heinemann Aging Males' Symptoms scale: a standardized instrument for the practice J Endocrinol Invest 28 Suppl. 11 2005 34 38 Proceedings
38. E. Nieschlag, and H.M. Behre Andrology 2nd ed. 2001 Springer New York
39. S. Bhasin, M. Pencina, G.K. Jasuja, T.G. Travison, A. Coviello, and E. Orwoll et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts J Clin Endocrinol Metab 96 8 2011 2430 2439
40. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 2009 1640 1645
41. A. Aversa, R. Bruzziches, D. Francomano, G. Rosano, A.M. Isidori, and A. Lenzi et al. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 10 2010 3495 3503
42. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol 73 5 2010 602 612
43. A. Aversa, R. Bruzziches, D. Francomano, E.A. Greco, R. Fornari, and L. Di Luigi et al. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study Aging Male 15 2 2012 96 102
44. A.A. Yassin, and G. Doros Testosterone therapy in hypogonadal men results insustained and clinically meaningful weight loss Clin Obes 3 2013 73 83
45. P. Wang, P.P. Menheere, A. Astrup, M.R. Andersen, M.A. Baak, and T.M. Larsen et al. Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men Obesity 21 10 2013 1997 2006
46. K.J. McInnes, L.B. Smith, N.I. Hunger, P.T. Saunders, R. Andrew, and B.R. Walker Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis Diabetes 61 5 2012 1072 1081
47. J.J. Avila, J.A. Gutierres, M.E. Sheehy, I.E. Lofgren, and M.J. Delmonico Effect of moderate intensity resistance training during weight loss on body composition and physical performance in overweight older adults Eur J Appl Physiol 109 3 2010 517 525
48. L. Avery, D. Flynn, A. van Wersch, F.F. Sniehotta, and M.I. Trenell Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions Diab Care 35 12 2012 2681 2689
49. A.E. Heufelder, F. Saad, M.C. Bunck, and L. Gooren Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone J Androl 30 6 2009 726 733
50. E.J. Giltay, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, F. Saad, and S.Y. Kalinchenko Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome J Sex Med 7 7 2010 2572 2582
51. C.C. Carson III, and G. Rosano Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data J Sex Med 9 1 2012 54 67